The Difference Between Learning Disabilities and ADHD

Weighing telepsychiatry vs in-person care means holding two findings at once. Across many mental health conditions, video psychiatry performs about as well as sitting in the same room. For severe mental illness (SMI) such as schizophrenia and bipolar disorder, the trials simply have not been run, and parts of this care (injections, blood tests, physical checks, and crisis assessment) cannot travel through a screen at all. So the real question is rarely either-or. It is which parts of care can safely go virtual, which parts cannot, and who should be making that call as your stability changes over time. Here's what the research shows, and where the practical limits fall.

What Telepsychiatry Is and What In-Person Care Means

Telepsychiatry is psychiatric care delivered by video or phone: evaluations, medication visits, and therapy sessions held from wherever the patient is. In-person care means visits at a clinic, with the clinician and everything a clinic contains (labs, injections, vitals, a team down the hall) physically present. Between them sits hybrid care, a deliberate mix of both formats, which is how a great deal of psychiatric care in the United States now actually runs. The terms matter less than what each format can physically deliver, which is where the comparison gets concrete.

What the Research Shows

The broadest comparison to date is a 2023 meta-analysis in the British Journal of Psychiatry covering 32 randomized trials and 3,592 participants across 11 conditions (Hagi et al., 2023). Pooled together, there was no significant overall difference in symptom improvement between telepsychiatry and face-to-face treatment. By condition, telepsychiatry did better for depressive disorders, across 6 trials, and face-to-face did better for eating disorders, on the strength of a single trial. Dropout findings split the same way, each direction supported by one small study. Several of the condition-level results rest on a single trial, which makes them fragile rather than final, and the authors note as much.

That finding cuts in both directions. Video care is not a watered-down version of psychiatry; for depression in particular it holds up well, and dismissing it would misread the data. At the same time, a pooled average across 11 conditions says nothing about the conditions that never made it into the trials, and the trials skew toward the diagnoses that are easiest to study remotely.

What We Know, and Do Not Yet Know, About SMI

Schizophrenia and bipolar disorder are largely missing from this evidence. A 2022 systematic review in JMIR Mental Health went looking for randomized trials of telehealth psychotherapy and found 12 trials with 931 patients, none of which studied schizophrenia or bipolar disorder, leading the authors to call for high-quality research before treating telehealth as equivalent for these conditions (Greenwood et al., 2022). The Hagi meta-analysis likewise names neither condition among its findings. Narrative reviews describe telehealth with psychosis as feasible and acceptable, and feasibility is a different claim than tested equivalence.

The absence of strong trials is not proof that telepsychiatry harms people with severe mental illness, and it is not proof of equivalence either. For conditions this serious, that gap counsels care in what gets moved online, and it puts the burden on care models to show their format choices serve the patient rather than the schedule.

What Needs to Happen In Person

Some components of SMI treatment are physical, and no quality of webcam changes that:

• Long-acting injectable antipsychotics are administered by a clinician, on a schedule, in person. For many people they are the backbone of stability.
• Blood monitoring comes with several core SMI medications: lithium levels, the regular blood counts recommended with clozapine, and metabolic monitoring for people on antipsychotics, per each medication's prescribing requirements. These need a clinic or a lab, not a login.
• Physical exams and vitals catch the medical problems that psychiatric medications can cause and that psychiatric illness so often hides from everyone, including the patient.
• Interventional treatments such as TMS and Spravato are delivered in clinic under supervision, by design.
• Crisis assessment is a hands-on clinical skill. Judging safety through a screen, with a person who may not want to be seen clearly and can end the call at will, is a genuinely harder task than assessing someone in the room.

For severe mental illness, these are routine, recurring parts of treatment rather than rare events, which is why fully remote care for this population runs into walls that have nothing to do with anyone's opinion of telehealth. A care plan that includes an injectable every four weeks and quarterly labs has an in-person spine no matter how the conversations happen.

Where Telepsychiatry Fits Well

Video visits earn their place in several situations: stable follow-ups and medication check-ins once a plan is working, access for people who live far from psychiatric care or cannot travel easily, and flexibility for family members joining a session from different places. For a routine fifteen-minute medication review in a stable month, driving an hour each way serves nobody.

Those are real advantages, and they come with real conditions. A video visit requires privacy at home, which not every household offers, a reliable connection, and the ability to engage through a screen, each of which gets harder exactly when symptoms are most active. Paranoia can make a camera feel threatening; depression can make logging in feel impossible. The format works best for the stable stretches of an illness that does not always stay stable.

Hybrid Care and Level of Need

The workable frame is level of need rather than loyalty to a format. Someone newly stabilized after a hospitalization needs more in-person contact: labs, physical checks, possibly injections, a team reading them closely. Someone two stable years into treatment may handle routine visits by video and come in for bloodwork and periodic full evaluations. A rough month might mean temporarily moving visits back on site.

The mix should shift as stability shifts, in both directions, and the people best positioned to adjust it are a care team who knows the whole picture, the same logic that separates outpatient from inpatient levels of care.

Why a Coordinated, In-Person Team Matters for SMI

Severe mental illness is a whole-body, whole-life illness, and people living with it face higher rates of serious physical illness, so treating it takes more than a sequence of appointments in any format. At Amae Health, one team (psychiatrists, therapists, and primary care physicians, along with peer mentors, care coordinators, dietitians, and health coaches) works from a shared plan in one place, so the injection, the lab draw, the therapy session, and the medical follow-up belong to one plan rather than four calendars. That is the part of care a screen cannot substitute for: not the conversation, which video carries fine, but the coordination and the physical medicine around it. It is the model behind our psychosis care and bipolar disorder treatment, and our full care model shows how the pieces fit.

Talking to Our Care Team About the Right Format

The right format is a clinical question with a moving answer: it depends on your current symptoms, your medications and their monitoring, your stability, and your goals. A first conversation can settle where to start and how to adjust from there. Reach out to our care team about the right format for this stage, and our patient and family resources describe what coordinated care involves.

Frequently Asked Questions

Is telepsychiatry as effective as in-person psychiatry?

For many conditions, yes. A 2023 meta-analysis of 32 randomized trials found no significant overall difference in symptom improvement, and telepsychiatry did best for depressive disorders. Results vary by condition, and evidence for schizophrenia and bipolar disorder specifically is limited.

Is telepsychiatry effective for schizophrenia?

The research is thin. A 2022 systematic review found no eligible randomized trials of telehealth psychotherapy for schizophrenia, while narrative reviews describe telehealth with psychosis as feasible and acceptable. Limited research is the accurate summary, not evidence of failure.

Can long-acting injectable antipsychotics be given by telehealth?

No. Injections are administered in person by a clinician, so people on long-acting injectables need in-person visits on their injection schedule, whatever else happens by video.

Do I need blood tests or physical checks with serious mental illness?

Often, yes, depending on the medication. Lithium requires blood level checks, clozapine calls for regular blood monitoring, and antipsychotics call for metabolic monitoring under their prescribing requirements, all of which involve a clinic or lab visit.

Can telepsychiatry handle a mental health crisis?

No. Video visits are not built for emergencies. In a crisis, call or text 988 or go to the nearest emergency room; a care team can take over treatment planning once the person is safe.

What is hybrid psychiatric care?

A deliberate mix of in-person and video visits, adjusted over time as stability and needs change. In-person time covers the parts of care that require presence, such as injections and labs, while routine check-ins can happen by video.

What if I am having thoughts of suicide?

Help is available right now, at any hour: call or text 988 for free, confidential support.

Citations

1. Hagi K, et al. "Telepsychiatry versus face-to-face treatment: systematic review and meta-analysis of randomised controlled trials." British Journal of Psychiatry, 2023;223(3):407-414. doi.org/10.1192/bjp.2023.86. Tier 1 (peer-reviewed meta-analysis).
2. Greenwood H, et al. "Telehealth versus face-to-face psychotherapy for less common mental health conditions: systematic review and meta-analysis." JMIR Mental Health, 2022;9(3):e31780. PMC8956990. Tier 1 (peer-reviewed systematic review).
3. 988 Suicide and Crisis Lifeline. 988lifeline.org. Tier 2 (FAQ only).

Maybe a psychiatrist mentioned a mood stabilizer and you're trying to understand what that means. Maybe you've read that they help with depression or anxiety and you're wondering whether that's true. Mood stabilizers are a real and important group of medications, but their main job is narrower than a lot of online articles suggest.

According to the NIMH, mood stabilizers are typically used to treat bipolar disorder and mood changes associated with other mental disorders. They are sometimes added to other medications for depression. For anxiety disorders, other medications are usually the first choice.

What are mood stabilizers?

Mood stabilizers are medications that reduce extreme shifts in mood, especially the highs of mania and the lows of bipolar depression, and help prevent new episodes. The main groups are:

• Lithium, which is approved for the treatment of mania and bipolar disorder
• Certain anticonvulsants, medications first developed for seizures, such as valproic acid (Depakote) and lamotrigine (Lamictal)
• Some antipsychotics, which are also used in bipolar disorder, though they aren't always called mood stabilizers

How do mood stabilizers work?

Lithium and the anticonvulsants act on the brain in different ways, which is part of why one person responds to lithium and another to an anticonvulsant. The NIMH notes, for example, that some anticonvulsants work better than lithium for people with "mixed" symptoms of mania and depression or with rapid-cycling bipolar disorder.

What matters most for patients is the effect: fewer and less severe mood episodes over time, rather than an immediate change in how you feel.

What mood stabilizers are used for

Bipolar disorder

This is the main use. According to MedlinePlus, lithium is used to treat and prevent episodes of mania in people with bipolar disorder. The NIMH adds that some studies indicate lithium may reduce the risk of suicide among people taking it for long-term maintenance.

For people with bipolar depression, the NIMH notes that health care providers typically prescribe a mood stabilizer along with an antidepressant to reduce the risk of switching into mania. We cover the full picture in effective bipolar disorder treatment and on our bipolar disorder treatment page.

Depression

The NIMH notes that mood stabilizers are sometimes used to treat depression, usually along with an antidepressant, or to augment the effect of other medications. That's an add-on role for specific situations, not a standard first treatment for depression. If depression has been severe or hard to treat, see what severe depression feels like.

Anxiety

Mood stabilizers aren't a standard treatment for anxiety disorders. According to the NIMH, anxiety is usually treated with antidepressants such as SSRIs and SNRIs, which health care providers typically start with for panic disorder and social anxiety disorder. Other options include buspirone, short-term benzodiazepines, and beta-blockers for physical symptoms. When anxiety comes with bipolar disorder, treating the bipolar disorder often matters most, which is where mood stabilizers come in.

Other uses

The NIMH also lists schizoaffective disorder and impulse-control disorders among the conditions where mood stabilizers are sometimes used.

Common mood stabilizers and their side effects

Lithium

Lithium needs close monitoring. The NIMH notes that people taking it generally have regular blood tests to check lithium levels and kidney and thyroid function, and MedlinePlus lists side effects including increased thirst, weight change, dry mouth, and stomach upset. Keeping lab appointments is part of taking lithium safely.

Lamotrigine (Lamictal)

According to MedlinePlus, lamotrigine is used to lengthen the time between mood episodes in people with bipolar I disorder. It hasn't been shown to treat an episode that's already happening. Its most important warning is a risk of rashes, including serious rashes that may need hospital treatment, which is why it's started at a low dose and increased slowly. MedlinePlus also notes that lamotrigine can make hormonal birth control less effective.

Valproic acid (Depakote)

Valproic acid is used to treat mania in bipolar disorder, according to MedlinePlus. It carries a serious warning for pregnancy: it can cause birth defects affecting the brain and spinal cord and can affect a child's learning and development. MedlinePlus advises women of childbearing age to discuss other possible treatments with their doctor.

Antipsychotics

Several antipsychotics are used in bipolar disorder. Their side effects differ, and some can affect weight, blood sugar, and cholesterol, so physical health monitoring is part of treatment.

Mood stabilizers vs. antidepressants

• Antidepressants treat depression and are also widely used for anxiety disorders. The NIMH notes they usually take 4 to 8 weeks to work.
• Mood stabilizers are mainly used to prevent and treat the highs and lows of bipolar disorder.

The difference matters most when someone might have bipolar disorder. That's why a careful evaluation of mood history, including any past periods of unusually high energy, little need for sleep, or racing thoughts, is an important part of choosing treatment.

What to know before and during treatment

• Finding the right medication can take time. The NIMH notes that it may take several tries to find the medication that works best with the fewest side effects.
• Don't stop suddenly. Changes to mood stabilizers should be made with a health care provider, because stopping abruptly can bring symptoms back.
• Monitoring is part of the treatment. Lithium and several anticonvulsants need regular blood tests.
• Pregnancy planning matters. Some mood stabilizers carry significant pregnancy risks, so family planning belongs in the treatment conversation.
• Supplements aren't substitutes. Herbal products and supplements can interact with psychiatric medications, and none has been shown to replace a mood stabilizer for bipolar disorder. MedlinePlus lists interactions and warnings for common herbs and supplements.

How we approach medication at Amae Health

Bipolar Disorder and Major Depressive Disorder are among the conditions our clinics specialize in. Our psychiatrists manage medication as part of one treatment plan, alongside therapists, primary care physicians, dietitians, and care coordinators, so lab monitoring, side effects, and physical health are tracked together. For people who need more than weekly care, we offer an Intensive Outpatient Program (IOP) and a Partial Hospitalization Program (PHP).

Frequently asked questions

Can mood stabilizers treat anxiety?

They aren't a standard treatment for anxiety disorders. The NIMH lists antidepressants such as SSRIs and SNRIs, buspirone, short-term benzodiazepines, and beta-blockers as the usual options. Mood stabilizers matter most when anxiety occurs alongside bipolar disorder.

Are mood stabilizers used for depression?

Sometimes. The NIMH notes they may be added to an antidepressant to boost its effect, and they're central to treating bipolar depression. They aren't a typical first treatment for depression on its own.

What is the most common mood stabilizer?

Lithium is approved for the treatment of mania and bipolar disorder, according to the NIMH. Lamotrigine and valproic acid are also widely used. Which one fits depends on the person's symptoms, history, and other health factors.

Do mood stabilizers change your personality?

They're meant to reduce extreme mood episodes, not change who you are. If a medication leaves you feeling flat or unlike yourself, that's important to raise with your prescriber, because dose adjustments or a different medication may help.

What happens if you stop taking a mood stabilizer suddenly?

Stopping abruptly can bring mood symptoms back. Any change should be planned with a health care provider.

Key takeaways

• Mood stabilizers are mainly used to treat and prevent the highs and lows of bipolar disorder.
• They're sometimes added to antidepressants for depression, but they aren't a standard treatment for anxiety disorders.
• Lithium may reduce suicide risk with long-term use and needs regular blood tests. Lamotrigine carries a serious rash warning, and valproic acid carries serious pregnancy risks.
• Medication works best with careful monitoring and as part of a broader treatment plan.

If you or someone you love is living with bipolar disorder or depression that hasn't responded to treatment, request an intake appointment. Our team will explain how an evaluation works and what the first visit involves.

Most people comparing TMS vs medication for depression arrive at the question the same way: the antidepressants have not brought enough relief. If that is you, it helps to know that both are evidence-based, FDA-cleared treatments, and they work in completely different ways. Medication adjusts brain chemistry from the inside. TMS stimulates the brain directly with magnetic pulses. Neither is universally better. The right choice depends on your treatment history, the severity of your symptoms, how you tolerate side effects, and your own preferences, especially once you are dealing with treatment-resistant depression or trying to figure out what to do when antidepressants don't work. This article compares the two fairly, not to push one over the other.

How Antidepressants Work

Antidepressants change the availability of certain brain chemicals, mainly serotonin and norepinephrine, that influence mood. The most common are SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors). Both are considered first-line treatment, meaning they are usually where a clinician starts.

‍

They are taken daily as a pill at home, and they work gradually. Most people need several weeks before the full effect shows, which is one of the harder parts of starting an antidepressant: you often have to wait to know whether it is working. Finding the right medication and dose regularly takes some trial and adjustment, and a first medication that does not help does not mean none will. There are many options within each class, so a clinician can switch or fine-tune based on how a person responds. Older tricyclic antidepressants (TCAs) also work but tend to cause harsher side effects, so they are usually reserved for later steps rather than first-line use. The main appeal of medication is convenience and evidence: it is taken at home, it is inexpensive, and it has decades of research behind it.

How TMS Works

Transcranial magnetic stimulation (TMS) is a non-invasive treatment that uses focused magnetic pulses, similar in strength to an MRI, to stimulate the mood-regulating areas of the brain that tend to be underactive in depression, mainly the left dorsolateral prefrontal cortex. It is FDA-cleared for major depressive disorder in adults, and also for OCD (NIMH, Brain Stimulation Therapies).

‍

TMS is not electroconvulsive therapy (ECT). There is no anesthesia and no sedation, and the patient stays fully awake through each session, then drives home and returns to normal activity. During a session, a coil rests against the scalp and delivers pulses in short cycles, which most people feel as a tapping sensation. A typical course runs about five days a week for several weeks, with each session lasting under an hour, and the benefit tends to build gradually across the course rather than after any single visit.

‍

As a non-drug option, TMS is one of the main alternatives to antidepressants for people whose medication has stopped short. It usually works best as part of a broader treatment plan, coordinated with therapy and, in many cases, ongoing medication, rather than as a replacement for all other care.

TMS vs Medication: Side-by-Side Comparison

The two treatments differ on almost every practical dimension, from how they are delivered to how quickly they work and what they ask of you day to day. The table below lays the key differences side by side, and the sections that follow unpack the two that matter most to people making this decision: side effects and success rates.

Side Effects Compared

Antidepressant side effects vary by class. SSRIs commonly cause weight gain and sexual dysfunction, though some effects ease after the first few weeks. SNRIs have a similar profile that is often milder. TCAs tend to be harsher, which is why they are rarely a first choice. These are systemic effects, because the medication acts throughout the body.

‍

TMS side effects are usually mild and short-lived: scalp discomfort, headache, or lightheadedness that typically passes soon after a session and lessens over the first week. The most serious risk, seizure, is very rare. Because TMS is non-invasive and targeted rather than systemic, it avoids the weight, sexual, and sleep side effects associated with medication, and it does not affect memory or cognition the way some people fear based on older brain treatments like ECT.

‍

It is not side-effect-free, though, and its main practical downside is different in kind. Instead of a daily side effect, TMS asks for a time commitment: traveling to a clinic most weekdays for several weeks. For someone with a demanding schedule or limited transportation, that logistical cost is real and worth weighing against the appeal of avoiding medication side effects. Neither profile is automatically easier to live with; they are simply different, and which one fits depends on the person.

Success Rates: What the Research Shows

Both treatments help many people, and neither helps everyone. Reading the numbers honestly matters more than cheerleading for either one. Two terms come up often: response means a meaningful reduction in symptoms, usually cutting them roughly in half, while remission means symptoms largely resolve. Remission is the higher bar and the real goal.

‍

For medication, the landmark STAR*D study found that roughly a third of patients reached remission on their first SSRI (Trivedi et al., American Journal of Psychiatry, 2006). That is a genuinely useful result for many people. But it also means most did not remit on the first try, and STAR*D showed that with each additional medication tried after a failure, the odds of remission tend to drop while side-effect burden tends to rise. That diminishing return is exactly the situation that leads people to look at other options.

‍

For TMS, a large real-world registry of more than 5,000 patients found that most experienced measurable improvement, with response rates ranging from about 58% to 83% and remission from about 28% to 62%, depending on how outcomes were measured (Sackeim et al., Journal of Affective Disorders, 2020). The wide ranges are worth noting: they reflect different rating scales and patient groups, and many of those patients were also taking medication, so the numbers describe TMS in real-world use rather than in isolation.

‍

For treatment-resistant depression specifically, a 2024 randomized trial compared TMS with switching or augmenting medication in 89 people who had not responded to at least two antidepressants, with both groups also receiving psychotherapy. The TMS group had significantly higher response and remission rates than the medication group (Dalhuisen et al., American Journal of Psychiatry, 2024). It is one of the clearest head-to-head comparisons available, though individual results always vary, and these figures describe groups, not guarantees for any one person.

When Antidepressants Don't Work: Where TMS Fits

About a third of people with major depressive disorder do not respond adequately to first-line treatment, a pattern clinicians call treatment-resistant depression. It is not a sign of personal failure or a rare edge case; it is common, and it has its own growing set of treatment options. When two or more medications have failed, or when side effects are intolerable, TMS becomes a well-supported next step, and the 2024 trial above is part of why it is increasingly positioned early in the treatment-resistant pathway rather than as a last resort.

‍

TMS is not the only option at this stage. Spravato (esketamine), a nasal spray derived from ketamine, is FDA-approved for treatment-resistant depression when used together with an oral antidepressant. It is given in a certified clinic under medical supervision, with monitoring after each dose, because of its dissociative effects. Combining TMS with an antidepressant is another route, and research suggests the combination can improve outcomes over medication alone. The larger point is that once first-line medication falls short, the path forward branches into several evidence-based options, and those branches are not mutually exclusive. A person might use medication and TMS together, or move from one approach to another as their psychiatrist learns what their brain responds to.

Who Is Each Treatment For?

Medication is often the right starting point for someone who is:

‍

• Early in treatment for depression
• Managing mild to moderate symptoms
• Looking to avoid in-clinic visits
• Someone who has responded well to an antidepressant before

‍

TMS is generally considered for someone who:

‍

• Has tried multiple antidepressants without adequate relief
• Cannot tolerate medication side effects
• Prefers a non-drug approach
• Has treatment-resistant depression

‍

Many people use both at different points, and some use them together. Where a person lands is a clinical decision, not a solo consumer choice, and it belongs with a psychiatrist who knows the full history.

Making the Decision With a Psychiatrist

TMS, medication, Spravato, and therapy are not competing products. They are tools a psychiatrist combines and adjusts based on diagnosis, history, and how a person responds over time. Comparing TMS and medication on paper is useful, but the decision is rarely either-or, and it is rarely one-and-done. It usually looks more like a sequence: start somewhere reasonable, measure the response, and adjust. The most reliable way to navigate that sequence, and to change course when needed, is a thorough evaluation within an integrated care setting, where the clinician managing your medication is the same one weighing whether TMS or another option fits.

‍

That is how care works at Amae Health. Our psychiatry-led teams evaluate the whole picture and coordinate treatment across medication, therapy, and procedures like TMS, which we offer at our Los Angeles clinic. You can explore our full range of treatments or, for severe depression that needs more structure, our Partial Hospitalization Program. Our resources for patients and families explain how integrated care works, and you can contact our team to ask about an evaluation.

Frequently Asked Questions

Is TMS better than medication for depression? Neither is universally better. Medication is first-line and works well for many people. For treatment-resistant depression, where two or more medications have failed, TMS often outperforms a medication switch. The right choice depends on history, severity, and side-effect tolerance.

‍

Can you do TMS and take antidepressants at the same time? Yes. TMS can be combined with antidepressants, and research suggests the combination can improve outcomes compared with medication alone. This should be coordinated by a psychiatrist.

‍

What are the side effects of TMS vs medication? TMS side effects are usually mild and short-lived, mainly scalp discomfort or headache that fades after the first week. Medication side effects vary but can include weight change, sexual dysfunction, and fatigue. Because it is non-invasive, TMS avoids the systemic side effects of medication.

‍

Does TMS work when antidepressants don't? Often, yes. TMS is specifically supported for treatment-resistant depression. A 2024 randomized trial found higher response and remission rates with TMS than with switching medications after failed trials. Individual results vary.

‍

How long does TMS treatment take? A typical course is sessions about five days a week for several weeks, each lasting under an hour. Antidepressants, by contrast, are taken daily and may take several weeks to show their full effect.

‍

What if neither TMS nor medication works? Other options exist, including Spravato (esketamine) used with an oral antidepressant, combination approaches, and structured programs like IOP or PHP for severe depression. A psychiatrist can help identify next steps. Depression is hard, and support is available: if you are struggling, call or text the 988 Suicide and Crisis Lifeline at 988, anytime.

‍

Citations

1. Trivedi MH, Rush AJ, Wisniewski SR, et al. "Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D." American Journal of Psychiatry, 2006. psychiatryonline.org. Tier 1 (peer-reviewed).
2. Sackeim HA, Aaronson ST, Carpenter LL, et al. "Clinical outcomes in a large registry of patients with major depressive disorder treated with transcranial magnetic stimulation." Journal of Affective Disorders, 2020. sciencedirect.com. Tier 1 (peer-reviewed).
3. Dalhuisen I, van Oostrom I, Spijker J, et al. "rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches." American Journal of Psychiatry, 2024. PubMed 39108161. Tier 1 (peer-reviewed RCT).
4. National Institute of Mental Health, "Brain Stimulation Therapies." nimh.nih.gov. Tier 2 (U.S. government).

‍

Further reading (external resources): NIMH, Depression; Mayo Clinic, Transcranial Magnetic Stimulation.

‍